Introduction to the Rosen Law Firm's Investigation
The Rosen Law Firm, a prominent global leader in investor rights, is currently investigating potential securities claims on behalf of investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO). This investigation arises from concerns that the company may have misled the investing public with materially inaccurate business information. It’s an essential moment for shareholders of Soleno Therapeutics to be informed and aware.
Investors’ Rights and Potential Compensation
If you are one of the many investors who acquired securities from Soleno Therapeutics, you might be eligible for compensation without any upfront costs through a contingency fee arrangement implemented by the Rosen Law Firm. By preparing a class action, the firm seeks to recover investor losses and ensure that the rights of investors are vigorously defended.
What Investors Should Know
Investors are encouraged to stay updated regarding the progress of this class action. If you believe your investment has been negatively impacted, consider taking action to protect your rights.
Details Surrounding the Investigation
The investigation intensified after a reported event, where a short report from Scorpion Capital raised alarming questions about the legitimacy of Soleno Therapeutics' recently approved treatment for Prader-Willi syndrome known as VYKAT XR. This report suggested severe safety concerns that could potentially jeopardize the pharmaceutical’s future market presence.
Impact on the Stock
Notably, following the revealing report on August 15, the stock of Soleno Therapeutics took a considerable hit, plummeting by 7.4%. It didn't stop there; the stock experienced a further decrease of 4.9% on the next trading day. These drastic changes in stock price underline the potential ramifications for shareholders and the overall integrity of the company’s disclosures.
The Importance of Experienced Legal Counsel
Choosing the right legal representation is crucial for investors involved in a class action. The Rosen Law Firm’s established reputation in handling similar cases sets them apart. They have a proven track record, recovering hundreds of millions for investors through leadership in securities class actions and shareholder derivative litigation.
Firm Achievements and Rankings
At one point, the firm achieved the largest securities class action settlement against a Chinese company and has consistently ranked at the top for their outstanding results. In 2019 alone, they recovered over $438 million for investors, showcasing their effectiveness and commitment to their clients.
Engaging with Rosen Law Firm
For ongoing updates, investors can follow the firm across various platforms such as LinkedIn, Twitter, and Facebook. It’s a simple way to remain informed about any developments in the class action and investment protections.
Contacting the Firm
If you have any inquiries regarding the class action against Soleno Therapeutics, you may reach out to Phillip Kim, Esq. Alternatively, it’s encouraged to visit their official website for more details on how to get involved.
Frequently Asked Questions
What prompted the investigation by the Rosen Law Firm?
The investigation was initiated due to allegations of materially misleading business information issued by Soleno Therapeutics that could have affected investors' decisions.
How can shareholders of Soleno Therapeutics participate in the class action?
Shareholders can join the class action through the Rosen Law Firm's website, where they can find more information on their legal rights and processes.
What are the potential outcomes of the class action?
The primary aim is to secure compensation for investors who suffered losses as a result of misleading information provided by Soleno Therapeutics.
Why is it important to select experienced legal counsel?
Experienced legal counsel can significantly improve the chances of a successful class action outcome, leveraging their track record and resources effectively for the benefit of investors.
What resources are available for investors?
The Rosen Law Firm provides various avenues for investors to get updates and information on their case and the broader implications for shareholders.
